Moderna announced Thursday that the company has asked the FDA to authorize a low-dose version of its COVID-19 vaccine as the first vaccine for children younger than age 5.
In a social media landscape shaped by hashtags, algorithms, and viral posts, nurse leaders must decide: Will they let the narrative spiral, or can they adapt and join the conversation?
...
